|
|
Office Locations:
|
719 Second Avenue, Suite 1402
Seattle, WA 98104
Phone: 206-438-1822
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Founded in 2016 by Dr. Boris Nikolic and Julie Sunderland, Biomatics Capital is a for-profit venture firm investing in transformational innovation at the intersection of health care and technology. Managing Directors Dr. Boris Nikolic and Julie Sunderland have invested together in emerging technology, health care and life science ventures since 2010. Biomatics closed its initial fund of $200 million, in excess of the fund target of $150 million. Biomatics estimates that it will invest in 15-20 companies through this fund, acting as Series A lead investor in a majority of the deals. Initial investments typically range from $5 million to $10 million, with up to $20 million over the life of the investment.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
